Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma
NCT00461786Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2004
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in ovarian cancer, primary peritoneal cancer (PPC), sponsored by Eli Lilly and Company. Started Sep 2004; status: completed.
02
Drugs
pemetrexed
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00461786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461786.